 |
Oral mucositis – sometimes a severe side effect of cancer treatment Oral mucositis is a painful inflammation and ulceration of the mucosal membranes in the mouth. It is a frequent side-effect of cancer treatment with radiation and chemotherapy (Ref 3). In severe cases, oral mucositis may be treatment limiting
with reduction in dosage or delays in the delivery of therapy (Ref 5).
Oral mucositis can in advanced stages be extremely painful, preventing the patient from eating and requiring hospitalization for re-hydration, opioid pain-medication,
and total parenteral nutrition (TPN) (Ref 4).
The destruction of the protective mucous membrane may further place the patient at a serious risk of infection.
episil® has been developed to protect the sore oral mucosal surfaces and to reduce the pain. Thereby, the patient’s ability to eat and drink will be maintained which will reduce the need for total parenteral nutrion and opiod analgesics (Ref 2). |
© Camurus AB, Ideon Science Park, 223 70 Lund, Sweden, info@camurus.com, www.camurus.com
episil® is Camurus registered trademark in US. Pending trademark applications in additional territories
episil® is Camurus registered trademark in US. Pending trademark applications in additional territories